U.S., Feb. 5 -- ClinicalTrials.gov registry received information related to the study (NCT07388069) titled 'Study of TN-001 Topical Eyedrops for Keratoconus' on Jan. 15.
Brief Summary: The goal of this clinical trial is to learn if TN-001, a new eye-drop therapy, is safe and well-tolerated in adult patients with progressive keratoconus. It will also provide data on whether this therapy is effective in treating keratoconus.
The main questions it aims to answer are:
What medical problems do participants have when using TN-001 eyedrops? Does TN-001 eyedrop therapy stop keratoconus from progressing further?
Participants will:
Take TN-001 eyedrops twice a day, every day, for 3-6 weeks. Visit the clinic once every week for checkups and tests...